(MedPage Today) — Note that some links may require registration or subscription. A cohort study found that diabetes patients taking GLP-1 receptor agonists had a higher risk of anterior ischemic optic neuropathy, a potentially blinding eye condition…
Source: MedPage Today — Headlines
